» Articles » PMID: 31285853

E1A Oncogene Induced Sensitization to NK Cell Induced Apoptosis Requires PIDD and Caspase-2

Overview
Date 2019 Jul 10
PMID 31285853
Authors
Affiliations
Soon will be listed here.
Abstract

Expression of the adenovirus E1A oncogene sensitizes tumor cells to innate immune rejection by NK cells. This increased NK sensitivity is only partly explained by an E1A-induced increase in target cell surface expression of NKG2D ligands. The post-recognition mechanisms by which E1A sensitizes cells to the apoptotic cell death response to NK injury remains to be defined. E1A sensitizes cells to apoptotic stimuli through two distinct mechanisms-repression of NF-κB-dependent antiapoptotic responses and enhancement of caspase-2 activation and related mitochondrial injury. The current studies examined the roles of each of these post-NKG2D-recognition pathways in the increased sensitivity of E1A-positive target cells to NK killing. Sensitization to NK-induced apoptosis was independent of E1A-mediated repression of cellular NF-κB responses but was dependent on the expression of both caspase-2 and the upstream, caspase-2 activating molecule, PIDD. Target cells lacking caspase-2 or PIDD expression retained E1A-induced increased expression of the NKG2D ligand, RAE-1. NK cell-induced mitochondrial injury of E1A-expressing cells did not require expression of the mitochondrial molecules, Bak or Bax. These results define a PIDD/caspase-2-dependent pathway, through which E1A sensitizes cells to NK-mediated cytolysis independently of and complementarily to E1A-enhanced NKG2D/RAE-1 ligand expression.

References
1.
Klefstrom J, Kovanen P, Somersalo K, Hueber A, Littlewood T, Evan G . c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors. Oncogene. 1999; 18(13):2181-8. DOI: 10.1038/sj.onc.1202546. View

2.
Shao R, Hu M, Zhou B, Lin S, Chiao P, von Lindern R . E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities. J Biol Chem. 1999; 274(31):21495-8. DOI: 10.1074/jbc.274.31.21495. View

3.
Cook J, Routes B, Walker T, Colvin K, Routes J . E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury. Exp Cell Res. 1999; 251(2):414-23. DOI: 10.1006/excr.1999.4597. View

4.
Cook J, Routes B, Leu C, Walker T, Colvin K . E1A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19 kDa protein. Exp Cell Res. 1999; 252(1):199-210. DOI: 10.1006/excr.1999.4617. View

5.
Routes J, Ryan S, Clase A, Miura T, Kuhl A, POTTER T . Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J Immunol. 2000; 165(8):4522-7. DOI: 10.4049/jimmunol.165.8.4522. View